Abstract
In the Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) study of TIA, short-term combination therapy with clopidogrel and aspirin reduced recurrent stroke.1 Whether all TIAs benefit equally from this treatment remains unclear. Given that dual antiplatelet therapy also promotes hemorrhage, identifying which TIAs derive the greatest benefit would be clinically useful.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
